Assessment of the performance of the plasma separation card for HIV-1 viral load monitoring in South Africa.


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
10 Apr 2024
Historique:
medline: 11 4 2024
pubmed: 12 3 2024
entrez: 12 3 2024
Statut: ppublish

Résumé

Scaling up of newer innovations that address the limitations of the dried blood spot and the logistics of plasma monitoring is needed. We employed a multi-site, cross-sectional assessment of the plasma separation card (PSC) on blood specimens collected from all consenting adults, assenting young and pediatric patients living with HIV from 10 primary healthcare clinics in South Africa. Venous blood for EDTA-plasma samples was collected and analyzed according to the standard of care assay, while collected capillary blood for the PSC samples was analyzed using the Roche COBAS AmpliPrep/Cobas TaqMan (CAP/CTM) HIV-1 Test at the National Reference laboratories. McNemar tests assessed the differences in concordance between the centrifuged plasma and dried plasma spots. The usability of PSC by blood spotting, PSC preparation, and pre-analytical work was assessed by collecting seven-point Likert-scale data from healthcare and laboratory workers. We enrolled 538 patients, mostly adults [ Findings from this manuscript emphasize the reliability of the plasma separation card (PSC), a novel diagnostic method that can be implemented in healthcare facilities in resource-constrained settings. The agreement of the PSC with the standard of care EDTA plasma for viral load monitoring is high. Since the findings showed that these tests were highly specific, we recommend a scale-up of PSC in South Africa for diagnosis of treatment failure.

Identifiants

pubmed: 38470024
doi: 10.1128/jcm.01649-23
pmc: PMC11026085
doi:

Substances chimiques

Edetic Acid 9G34HU7RV0
RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0164923

Subventions

Organisme : HHS | Centers for Disease Control and Prevention (CDC)
ID : GH001981

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

J Clin Microbiol. 2016 Jun;54(6):1641-1643
pubmed: 27008874
J Antimicrob Chemother. 2009 Jul;64(1):33-6
pubmed: 19403653
Clin Infect Dis. 2016 Apr 15;62(8):1043-8
pubmed: 26743094
PLoS One. 2016 Jul 06;11(7):e0158881
pubmed: 27383834
PLoS One. 2020 May 6;15(5):e0232122
pubmed: 32374748
PLoS One. 2016 Dec 16;11(12):e0168244
pubmed: 27992495
J Clin Microbiol. 2019 Mar 28;57(4):
pubmed: 30728197
Antivir Ther. 2009;14(5):619-29
pubmed: 19704164
PLoS One. 2017 Jun 16;12(6):e0179316
pubmed: 28622370
J Virol Methods. 2017 Jun;244:39-45
pubmed: 28274744
Trop Med Int Health. 2009 Oct;14(10):1220-5
pubmed: 19624478
PLOS Glob Public Health. 2023 Jun 28;3(6):e0002099
pubmed: 37379313
J Clin Virol. 2021 Jul;140:104839
pubmed: 33991979
BMC Infect Dis. 2022 May 17;22(1):474
pubmed: 35581555

Auteurs

Lucy Chimoyi (L)

Implementation Research Division, The Aurum Institute, Johannesburg, South Africa.

Lucia Hans (L)

Department of Molecular Medicine and Hematology, National Health Laboratory Service, Johannesburg, South Africa.
Department of Molecular Medicine and Hematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Matthew Oladimeji (M)

Implementation Research Division, The Aurum Institute, Johannesburg, South Africa.

Gurpreet Kindra (G)

Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Pretoria, South Africa.

Karidia Diallo (K)

Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Pretoria, South Africa.

Kassahun Ayalew (K)

Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Pretoria, South Africa.

Geoffrey K Setswe (GK)

Implementation Research Division, The Aurum Institute, Johannesburg, South Africa.
Department of Health Studies, University of South Africa, Pretoria, South Africa.

Sergio Carmona (S)

Department of Molecular Medicine and Hematology, National Health Laboratory Service, Johannesburg, South Africa.
Department of Molecular Medicine and Hematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH